1. Home
  2. AIRS vs DBL Comparison

AIRS vs DBL Comparison

Compare AIRS & DBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIRS

AirSculpt Technologies Inc.

N/A

Current Price

$2.45

Market Cap

328.7M

Sector

Health Care

ML Signal

N/A

Logo DoubleLine Opportunistic Credit Fund of Beneficial Interest

DBL

DoubleLine Opportunistic Credit Fund of Beneficial Interest

N/A

Current Price

$14.09

Market Cap

285.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRS
DBL
Founded
2012
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
328.7M
285.5M
IPO Year
2021
2011

Fundamental Metrics

Financial Performance
Metric
AIRS
DBL
Price
$2.45
$14.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.0M
48.7K
Earning Date
05-12-2026
01-01-0001
Dividend Yield
N/A
8.67%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$151,818,000.00
N/A
Revenue This Year
$5.19
N/A
Revenue Next Year
$5.32
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.51
$13.95
52 Week High
$12.00
$15.79

Technical Indicators

Market Signals
Indicator
AIRS
DBL
Relative Strength Index (RSI) 30.39 53.61
Support Level $2.43 $14.13
Resistance Level $3.36 $14.44
Average True Range (ATR) 0.21 0.09
MACD -0.01 0.00
Stochastic Oscillator 4.11 57.71

Price Performance

Historical Comparison
AIRS
DBL

About AIRS AirSculpt Technologies Inc.

AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.

About DBL DoubleLine Opportunistic Credit Fund of Beneficial Interest

Doubleline Opportunistic Credit Fund operates as a closed-end management investment company. Its investment objective is to seek a high total investment return by providing a high level of current income and the potential for capital appreciation. The Fund invests in debt securities, residential and commercial mortgage-backed securities, asset-backed securities, U.S. Government securities, corporate debt, international sovereign debt, and short-term investments.

Share on Social Networks: